Methods of preparing crosslinked materials and bioprosthetic...

Details Methods of preparing crosslinked materials and bioprosthetic... Methods of preparing crosslinked materials and bioprosthetic...

2006-05-30

2006-05-30

Carlson, Karen Cochrane (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07053051

ABSTRACT:
Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.

REFERENCES:
patent: 4279812 (1981-07-01), Cioca
patent: 4687841 (1987-08-01), Spilburg et al.
patent: 4958008 (1990-09-01), Petite et al.
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5264551 (1993-11-01), Petite et al.
patent: 5306782 (1994-04-01), Chang et al.
patent: 5374539 (1994-12-01), Nimni et al.
patent: 5639796 (1997-06-01), Lee
patent: 5674725 (1997-10-01), Beertsen et al.
patent: 5733994 (1998-03-01), Koepff et al.
patent: 5782931 (1998-07-01), Yang et al.
patent: 6117979 (2000-09-01), Hendriks et al.
patent: 6166184 (2000-12-01), Hendriks et al.
patent: 6330481 (2001-12-01), Van Wijk et al.
patent: 6385491 (2002-05-01), Lindemans et al.
patent: 2002/0022588 (2002-02-01), Wilkie et al.
patent: 2002/0028243 (2002-03-01), Masters
patent: 2002/0038004 (2002-03-01), Stolowitz et al.
patent: 2002/0038150 (2002-03-01), Urry
patent: 0897942 (1988-08-01), None
patent: 0898973 (1998-08-01), None
patent: 1 172 399 (2002-01-01), None
patent: 6-293870 (1994-10-01), None
patent: 7-316193 (1995-12-01), None
patent: 2002-80501 (2002-03-01), None
patent: WO 85/04413 (1985-10-01), None
patent: WO 93/00935 (1993-01-01), None
patent: WO 93/10231 (1993-05-01), None
patent: WO 96/03093 (1996-02-01), None
patent: WO 00/33888 (2000-06-01), None
patent: WO 00/35372 (2000-06-01), None
patent: WO 00/52052 (2000-09-01), None
patent: WO 00/56885 (2000-09-01), None
patent: WO 00/72872 (2000-12-01), None
patent: WO 00/72893 (2000-12-01), None
patent: WO 01/45761 (2001-06-01), None
patent: WO 01/61353 (2001-08-01), None
patent: WO 01/91821 (2001-12-01), None
patent: WO 01/92322 (2001-12-01), None
patent: WO 02/05959 (2002-01-01), None
patent: WO 02/09647 (2002-02-01), None
patent: WO 02/34306 (2002-05-01), None
Damnik et al., Biomaterials, (1996), v. 17(8), pp. 765-773.
U.S. Appl. No. 60/514,881 filed Oct. 28, 2003, Hendriks et al.
Gratzer et al., “Control of pH Alters the Type of Cross-linking Produced by 1-Ethyl-3-(3-Dimethylaminopropyl)-Carbodiimide (EDC) Treatment of Acellular Matrix Vascular Grafts,”J. Biomed. Mat. Res., 2001;58:172-179.
Hafemann et al., “Crosslinking by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) of a collagen/elastin membrane meant to be used as a dermal substitute; effects on physical, biochemical and biological features in vitro,”J. Mat. Sci.: Mat. Med., 2001;12:437-446.
Heidemann et al., “Polycondensation of tripeptides by a one pot procedure,”Die Makromol. Chem., 1973;166:1-14 (English language summary).
Hypolite et al., “Formation of Microscale Gradients of Protein Using Heterobifunctional Photolinkers,”Bioconjugate Chem., 1997;8:658-663.
Katchalski, “Novel Techniques for the Synthesis of Linear and Cyclic Peptides,”Hypotensive Pept., Proc. Int. Symp., 1966; meeting date Oct. 25-29, 1965:55-62.
Kim et al., “Three-Dimensional Porous Collagen/Chitosan Complex Sponge for Tissue Engineering.”Fibers and Polymers, 2001;2(2):64-70.
Kuijpers et al., “Characterization of the Network Structure of Carbodiimide Crosslinked Gelatin Gels,”Macromolecules, 1999;32:3325-3333.
Kuroyanagi et al., “Preparation of graft polypeptide binding bleomycin derivative,”Int. J. Biol. Macromol., 1986;8:52-56.
Lee et al., “Crosslinking of tissue-derived biomaterials in 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC),”J. Mat. Sci: Mat. Med., 1996;7:531-541.
Nishino et al., “Peptide Hydroxamic Acids as Inhibitors of Thermolysin,”Biochemistry, 1978;17(14):2846-2850.
Olde Damink, “Cross-linking of dermal sheep collagen using a water-soluble carbodiimide,”Biomaterials, 1996;17:765-773.
Olde Damink et al., “In vitro degration of dermal sheep collagen cross-linked using a water-soluble carbodiimide,”Biomaterials, 1996;17:679-84.
Pieper et al., “Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects,”Biomaterials, 2000;21: 581-593.
Shibnev et al., “N-hydroxysuccinimide Esters in the Synthesis of Collagen-Type Structures,”Bulletin of the Academy of Sciences of the USSR (translation of Izv. Akad. Nauk SSSR, Ser. Khim.), 1969;11:2367-2370.
Shibnev et al., “Synthesis of Different Activated Esters of Monomeric Tripeptides in Order to Obtain a Model of the Collagen Structure,”Bulletin of the Academy of Sciences of the USSR(translation of Izv. Akad. Nauk SSSR, Ser. Khim.), 1969;11:2362-2366.
van Wachem et al., “Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen,”J. Biomed. Mat. Res., 1994;28:353-363.
van Wachem et al., “In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading,”J. Biomed. Mat. Res., 2001;55(3):368-378.
Wissink et al., “Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices,”J. Control. Release, 2000;64:103-114.
Wissink et al., “Endothelial cell seeding of (heparinized) collagen matrices: effects of bFGF pre-loading on proliferation (after low density seeding) and pro-coagulant factors,”J. Control Release, 2000;67:141-155.
Wissink et al., “Binding and release of basic fibroblast growth factor from heparinized collagen matrices,”Biomaterials, 2001;22:2291-2299.
Wissink et al., “Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation,”Biomaterials, 2001;22:151-163.
Zeeman et al., “Successive epoxy and carbodiimide crosslinking of dermal sheep collagen,”Biomaterials, 1999;20:921-931.
Wissink et al., “Endothelial Cell Seeding on Crosslinked Collagen: Effects of Crosslinking on Endothelial Cell Proliferation and Functional Parameters,”Thrombosis and Haemostatis, 2000;84:325-331.

Affiliated with

Also associated with

Rating

Methods of preparing crosslinked materials and bioprosthetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of preparing crosslinked materials and bioprosthetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of preparing crosslinked materials and bioprosthetic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3587937